A comparative effectiveness research study compared MACE rates among initiators of sulfonylureas versus DPP4 inhibitors for T2D. Glipizide in particular showed a significant link to cardiovascular ...
When it comes to managing type 2 diabetes, most of us worry about blood sugar levels, not our heart. But a recent study is shaking things up by pointing fingers not at the disease itself but at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results